Yun Lin

2.8k total citations · 1 hit paper
37 papers, 2.1k citations indexed

About

Yun Lin is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yun Lin has authored 37 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 13 papers in Cancer Research and 9 papers in Oncology. Recurrent topics in Yun Lin's work include Nanoplatforms for cancer theranostics (7 papers), RNA modifications and cancer (6 papers) and Cancer-related molecular mechanisms research (5 papers). Yun Lin is often cited by papers focused on Nanoplatforms for cancer theranostics (7 papers), RNA modifications and cancer (6 papers) and Cancer-related molecular mechanisms research (5 papers). Yun Lin collaborates with scholars based in China, United States and Switzerland. Yun Lin's co-authors include Chunyan Dong, Yan Gu, Dan Han, Nan Li, Cheng Qian, Jiangxue Li, Jin Hou, Xuetao Cao, Huamin Wang and Mingyan Huang and has published in prestigious journals such as Advanced Materials, PLoS ONE and Hepatology.

In The Last Decade

Yun Lin

37 papers receiving 2.0k citations

Hit Papers

Circular RNA circMTO1 acts as the sponge of microRNA‐9 to... 2017 2026 2020 2023 2017 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Circular RNA circMTO1 acts as the sponge of microRNA‐9 to suppress hepatocellular carcinoma progression
    2017 939 citations Dan Han, Jiangxue Li et al. Hepatology profile →

Peers

Yun Lin
Masaki Morishita Japan
Junxing Huang China
Jingjing Pan China
Yunhao Chen China
Xiaoming Lyu China
Bo Su China
Rajesh Mukthavaram United States
Zhengkui Zhang China
Wenxian Guan China
Xiaofeng Xue China
Masaki Morishita Japan
Yun Lin
Citations per year, relative to Yun Lin Yun Lin (= 1×) peers Masaki Morishita

Countries citing papers authored by Yun Lin

Since Specialization
Citations

This map shows the geographic impact of Yun Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yun Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yun Lin more than expected).

Fields of papers citing papers by Yun Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yun Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yun Lin. The network helps show where Yun Lin may publish in the future.

Co-authorship network of co-authors of Yun Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Yun Lin. A scholar is included among the top collaborators of Yun Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yun Lin. Yun Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yin, Beibei, et al.. (2024). The prognostic value and its relationship with immune infiltration of ACLY in clear cell renal cell carcinoma. Translational Oncology. 47. 102056–102056. 5 indexed citations
2.
Lin, Zhijuan, Yueting Huang, Yun Lin, et al.. (2024). Real-world experience with venetoclax-based therapy for patients with myeloid sarcoma. Discover Oncology. 15(1). 210–210. 1 indexed citations
3.
4.
Wang, Li, et al.. (2023). LDHA as a regulator of T cell fate and its mechanisms in disease. Biomedicine & Pharmacotherapy. 158. 114164–114164. 31 indexed citations
5.
Sun, Shujun, et al.. (2023). Immunoregulatory mechanism of acute kidney injury in sepsis: A Narrative Review. Biomedicine & Pharmacotherapy. 159. 114202–114202. 33 indexed citations
6.
Liu, Jie, Xiaochun Hu, Lei Feng, et al.. (2022). Carbonic anhydrase IX-targeted H-APBC nanosystem combined with phototherapy facilitates the efficacy of PI3K/mTOR inhibitor and resists HIF-1α-dependent tumor hypoxia adaptation. Journal of Nanobiotechnology. 20(1). 187–187. 22 indexed citations
7.
Li, Huanqin, Shumin Liu, Yun Lin, et al.. (2022). Identification and Verification of Ubiquitin D as a Gene Associated with Hepatitis C Virus-Induced Hepatocellular Carcinoma. Intervirology. 65(4). 195–205. 4 indexed citations
8.
Song, Zhiwang, Xia Zhang, Yun Lin, et al.. (2019). LINC01133 inhibits breast cancer invasion and metastasis by negatively regulating SOX4 expression through EZH2. Journal of Cellular and Molecular Medicine. 23(11). 7554–7565. 54 indexed citations
9.
10.
Feng, Chan, Lv Chen, Yonglin Lu, et al.. (2019). Programmable Ce6 Delivery via Cyclopamine Based Tumor Microenvironment Modulating Nano-System for Enhanced Photodynamic Therapy in Breast Cancer. Frontiers in Chemistry. 7. 608312–608312. 12 indexed citations
11.
Feng, Chan, Kun Wang, Yun Lin, et al.. (2018). Extracellular retention of a cyclopamine nanoformulation leveraging larger size and more negative charge for improved breast cancer treatment. Journal of Materials Chemistry. 1 indexed citations
12.
Lin, Yun, Zhijuan Lin, Li Z, et al.. (2018). The prognostic impact of long noncoding RNA HOTAIR in leukemia and lymphoma: a meta-analysis. Hematology. 23(9). 600–607. 10 indexed citations
13.
Song, Zhiwang, Chan Feng, Yonglin Lu, Yun Lin, & Chunyan Dong. (2017). PHGDH is an independent prognosis marker and contributes cell proliferation, migration and invasion in human pancreatic cancer. Gene. 642. 43–50. 69 indexed citations
14.
Han, Dan, Jiangxue Li, Huamin Wang, et al.. (2017). Circular RNA circMTO1 acts as the sponge of microRNA‐9 to suppress hepatocellular carcinoma progression. Hepatology. 66(4). 1151–1164. 939 indexed citations breakdown →
15.
Song, Zhiwang, Yun Lin, Xiao-Juan Ye, et al.. (2016). Expression of IL-1α and IL-6 is Associated with Progression and Prognosis of Human Cervical Cancer. Medical Science Monitor. 22. 4475–4481. 64 indexed citations
16.
Li, Qi, Dong Zhao, Yun Lin, et al.. (2013). The rs2233678 Polymorphism in PIN1 Promoter Region Reduced Cancer Risk: A Meta-Analysis. PLoS ONE. 8(7). e68148–e68148. 20 indexed citations
17.
Jiang, Hong, Yun Lin, Changqing Yang, et al.. (2012). Quantitative assessment of the association between XRCC6 C1310G polymorphism and cancer risk. Tumor Biology. 34(2). 779–785. 2 indexed citations
18.
Li, Zhihui, Shuwen Wu, Jingjing Wang, et al.. (2012). Evaluation of the interactions of HIV-1 integrase with small ubiquitin-like modifiers and their conjugation enzyme Ubc9. International Journal of Molecular Medicine. 30(5). 1053–1060. 13 indexed citations
19.
Huang, Jian, Yun Lin, Lihua Li, et al.. (2008). ARHI, as a novel suppressor of cell growth and downregulated in human hepatocellular carcinoma, could contribute to hepatocarcinogenesis. Molecular Carcinogenesis. 48(2). 130–140. 26 indexed citations
20.
Sætrom, Pål, et al.. (2006). Conserved MicroRNA Characteristics in Mammals. Oligonucleotides. 16(2). 115–144. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masaki Morishita Breakdown of academic impact, for papers by Junxing Huang Breakdown of academic impact, for papers by Jingjing Pan Breakdown of academic impact, for papers by Yunhao Chen Breakdown of academic impact, for papers by Xiaoming Lyu Breakdown of academic impact, for papers by Bo Su Breakdown of academic impact, for papers by Rajesh Mukthavaram Breakdown of academic impact, for papers by Zhengkui Zhang Breakdown of academic impact, for papers by Wenxian Guan Breakdown of academic impact, for papers by Xiaofeng Xue
Rankless by CCL
2026